The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention

Autor: Andrea Podczeck-Schweighofer, Georg Delle-Karth, Jolanta M. Siller-Matula, Marcel Francesconi, Günter Christ, Carina Gruber, Bernd Jilma, Cornelia Dechant, Katharina Grohs
Rok vydání: 2014
Předmět:
Zdroj: Clinical science (London, England : 1979). 128(2)
ISSN: 1470-8736
Popis: This was a prospective study comparing two groups: personalized and non-personalized treatment with P2Y12 receptor blockers during a 12-month follow-up. We aimed to investigate whether personalized antiplatelet treatment in patients with high on-treatment platelet reactivity (HTPR) improves clinical outcome. Platelet reactivity was assessed by adenosine diphosphate induced aggregation using a multiple electrode aggregometry (MEA) in 798 patients with coronary artery disease undergoing percutaneous coronary intervention (PCI). Patients with HTPR received up to four repeated loading doses of clopidogrel or prasugrel in the personalized treatment group (n=403), whereas no change in the treatment strategy was undertaken in patients with HTPR in the non-personalized treatment group (n=395). There were fewer major adverse cardiac events (MACE) in the personalized treatment group than in the non-personalized treatment group (7.4% compared with 15.3% respectively; P
Databáze: OpenAIRE